Back to Results
First PageMeta Content
Pharmacology / Pharmaceutical industry / Pharmaceutical sciences / Organofluorides / Selective serotonin reuptake inhibitors / Abbreviated New Drug Application / Generic drug / Paroxetine / Antidepressant / Chemistry / Organic chemistry / Pharmaceuticals policy


Patented Medicine Prices Review Board Conseil d’examen du prix des médicaments
Add to Reading List

Document Date: 2013-01-18 14:32:50


Open Document

File Size: 800,67 KB

Share Result on Facebook

City

Ottawa / /

Country

Canada / /

/

Event

Diplomatic Relations / /

Facility

Canadian Institute / /

/

IndustryTerm

substitute product / generic drug product / drug product / prescription drug products / pharmaceutical trends / pharmaceutical market / drug products / pmprb@pmprb-cepmb.gc.ca Web / overall pharmaceutical market / /

NaturalFeature

Edward Island / /

Organization

Patented Medicine Prices Review Board / NPDUIS Steering Committee / Canadian Institute for Health Information / /

Person

Paroxetine (Paxil) Gabapentin / Pravastatin (Pravacol) Citalopram / Drug Omeprazole (Losec) / Citalopram (Celexa) Paroxetine / /

/

Position

Executive Summary Introduction General / physician / Minister of Health / General / Contents Executive / /

Product

Celexa / Neurontin / simvastatin / gabapentin / risperidone / Paxil / omeprazole / Zocor / /

ProvinceOrState

Alberta / New Brunswick / Saskatchewan / Manitoba / Prince Edward Island / Nova Scotia / British Columbia / Ontario / /

Technology

PDF / /

URL

www.pmprb-cepmb.gc.ca / /

SocialTag